GABA-A Receptor Associated Protein Like Protein 2 (GABARAPL2) Antibody

Este producto es parte de GABARAPL - GABA A Receptor Associated Protein Like Protein
Product Graph
286€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
GABA-A Receptor Associated Protein Like Protein 2 (GABARAPL2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx128282
tested applications
WB, IHC, IF/ICC

Description

GABARAPL2 Antibody is a Rabbit Polyclonal against GABARAPL2.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
GABA-A Receptor Associated Protein Like Protein 2 (GABARAPL2)
Host
Rabbit
Reactivity
Human
Recommended Dilution
WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Purification
Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography.
Size 1
100 µl
Size 2
200 µl
Size 3
1 ml
Form
Liquid
Tested Applications
WB, IHC, IF/ICC
Buffer
0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
Availability
Shipped within 5-7 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P60520
Alias
ATG8,ATG8C,GATE-16,GATE16,GEF-2,GEF2
Background
Antibody anti-GABARAPL2
Status
RUO

Descripción

GABARAPL2, another member of the GABARAP family, is essential for receptor trafficking, intracellular transport, and autophagy regulation. Like GABARAPL1, GABARAPL2 interacts with GABA-A receptors to facilitate their trafficking and proper membrane localization, maintaining synaptic inhibitory neurotransmission. It is also a core component of the autophagy machinery, functioning in autophagosome formation and lysosomal delivery of cargo proteins. GABARAPL2 interacts with autophagy-related proteins like LC3 and ATG8 to mediate selective autophagy processes, including the degradation of misfolded proteins and damaged organelles. Dysregulation of GABARAPL2 is associated with neurodegenerative disorders, such as Huntington’s and ALS, where defective autophagy contributes to protein aggregation and neuronal loss. In cancer, GABARAPL2 plays a dual role, promoting survival or apoptosis depending on cellular context, highlighting its involvement in tumor growth and chemoresistance. Its role in maintaining cellular homeostasis through autophagy and receptor regulation makes GABARAPL2 a promising therapeutic target for neurodegenerative diseases and cancer.

Related Products

FNab03277

GABARAPL2 antibody

Ver Producto
FNab03278

GABARAPL2-Specific antibody

Ver Producto
P2304

Recombinant Human GABARAPL2

Ver Producto